Final Biochemical Control | Presenting Uncontrolled Without Prior Treatment for Acromegaly n = 40 (54.1%) | Presenting Uncontrolled with Prior Treatment for Acromegaly n = 34 (45.9%) | All N = 74 | |||
---|---|---|---|---|---|---|
Controlled n = 33 (82.5%) | Uncontrolled n = 7 (17.5%) | Controlled n = 17 (50.0%) | Uncontrolled n = 17 (50.0%) | |||
Age at index date, yeara | ||||||
 mean | 44.5 | 45.6 | 46.8 | 53.4 | 47.2 | |
 (SD) | (15.9) | (14.5) | (12.9) | (17.7) | (15.6) | |
Age at diagnosis, yearb | ||||||
 N | 30 | 5 | 16 | 15 | 66 | |
 mean | 44.5 | 40.0 | 41.4 | 43.6 | 43.2 | |
 (SD) | (15.9) | (13.6) | (12.1) | (16.1) | (14.7) | |
Years of follow-up at center | ||||||
 mean | 5.0 | 5.3 | 8.7 | 8.3 | 6.7 | |
 (SD) | (4.7) | (2.7) | (6.3) | (5.3) | (5.3) | |
 min-max | 0.3-23.0 | 2.2-9.4 | 0.2-21.3 | 0.6-20.2 | 0.2-23.0 | |
 median | 4.2 | 4.5 | 8.0 | 7.3 | 4.9 | |
Tumor Sizec | ||||||
  n | 31 | 5 | 15 | 14 | 65 | |
 Macroadenoma | ||||||
  n | 29 | 4 | 14 | 12 | 59 | |
  (%) | (93.5) | (80.0) | (93.3) | (85.7) | (90.8) | |
 Microadenoma | ||||||
  n | 2 | 1 | 1 | 2 | 6 | |
  (%) | (6.5) | (20.0) | (6.7) | (14.3) | (9.2) | |
Abnormal finding on MRI or CT | ||||||
 n | 21 | 4 | 7 | 8 | 40 | |
 (%) | (63.6) | (57.1) | (41.2) | (47.1) | (54.1) | |
Hormonal Abnormalities | ||||||
 Prolactin elevation | ||||||
  n | 0 | 0 | 0 | 1 | 1 | |
  (%) | (0.0) | (0.0) | (0.0) | (5.9) | (1.4) | |
 Adrenal insufficiency | ||||||
  n | 2 | 2 | 1 | 2 | 7 | |
  (%) | (6.1) | (28.6) | (5.9) | (11.8) | (9.5) | |
 Gonadal insufficiency | ||||||
  n | 4 | 1 | 4 | 0 | 9 | |
  (%) | (12.1) | (14.3) | (23.5) | (0.0) | (12.2) | |
 Hypothyroidism | ||||||
  n | 3 | 1 | 2 | 4 | 10 | |
  (%) | (9.1) | (14.3) | (11.8) | (23.5) | (13.5) |